Back
Kiniksa Pharmaceuticals Vs. Akebia Therapeutics Industry Stock Comparison
Buy
65
KNSA
Kiniksa Pharmaceuticals
Last Price:
19.76
Seasonality Move:
6.55%
Sell
42
AKBA
Akebia Therapeutics
Last Price:
1.16
Seasonality Move:
-7.41%
Buy
65
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals [KNSA] share price is $19.77. The Score for KNSA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- KNSA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.15. The Score for AKBA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- AKBA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals's stock price today?
-
The Kiniksa Pharmaceuticals share price today is $19.77
The current trend is moderately bullish and KNSA is experiencing selling pressure, which indicates risk of future bearish movement.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight selling pressure.
KNSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 57.46 | Buy |
| Chaikin Money Flow: | -201585 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.54 - 20) | Buy |
| Bollinger Bands (100): | (18.01 - 20.25) | Buy |
AKBA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 36.32 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.23 - 1.41) | Sell |
| Bollinger Bands (100): | (1.29 - 1.73) | Sell |
KNSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.88 | Sell |
| 20-day SMA: | 19.18 | Buy |
| 50-day SMA: | 19.01 | Buy |
| 200-day SMA: | 17.93 | Buy |
| 8-day EMA: | 19.8 | Sell |
| 20-day EMA: | 19.37 | Buy |
| 50-day EMA: | 19.08 | Buy |
| 200-day EMA: | 17.84 | Buy |
AKBA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.24 | Sell |
| 20-day SMA: | 1.3 | Sell |
| 50-day SMA: | 1.5 | Sell |
| 200-day SMA: | 1.31 | Sell |
| 8-day EMA: | 1.22 | Sell |
| 20-day EMA: | 1.31 | Sell |
| 50-day EMA: | 1.41 | Sell |
| 200-day EMA: | 1.32 | Sell |
Kiniksa Pharmaceuticals Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $0.49 per share.
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.05 per share.
Kiniksa Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akebia Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||